baxter international inc (BAX:New York)
Robert M. Davis J.D.
Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
|Age||Total Calculated Compensation||This person is connected to 131 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Mr. Robert M. Davis, also known as Rob, has been Chief Financial Officer and Executive Vice President at Merck & Co. Inc. since April 23, 2014. He is an Advisor at HealthQuest Capital. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President at Medical Products from October 2010 to March 27, 2014. Mr. Davis served as the President at Renal at Baxter International Inc. from July 5, ...
One Baxter ParkwayPhone: 224-948-2000
Deerfield, Illinois 60015
Board Members Memberships*
Northwestern University School of Law
J.L. Kellogg School of Management, Northwestern University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.1M||Compensation as of Fiscal Year 2013.|